LY294002 targets PI3K
Evidence from:
primary |
all sources
Evidence (5 sources)
Establishment of human iPSC-based models for the study and targeting of glioma initiating cells.
(2016)
PMID:26899176
cited
PI3K ... inhibitor LY294002
confidence: 0.96
Establishment of human iPSC-based models for the study and targeting of glioma initiating cells.
(2016)
PMID:26899176
cited
PI3K (LY294002; 5 μM) ... inhibitors
confidence: 0.95
Establishment of human iPSC-based models for the study and targeting of glioma initiating cells.
(2016)
PMID:26899176
cited
evaluate the effect of the respective PI3K ... inhibitors LY294002 ...
confidence: 0.96
Establishment of human iPSC-based models for the study and targeting of glioma initiating cells.
(2016)
PMID:26899176
cited
PI3K inhibitor LY294002 10 μM
confidence: 0.96
Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation.
(2009)
PMID:18823877
cited
the PI3K inhibitor LY294002 partially reduced the effect of d-fenfluramine
confidence: 0.90